Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Nutex Health Inc (NASDAQ: NUTX) closed at $119.00 up 3.03% from its previous closing price of $115.50. In other words, the price has increased by $3.03 from its previous closing price. On the day, 0.12 million shares were traded. NUTX stock price reached its highest trading level at $121.6 during the session, while it also had its lowest trading level at $112.575.
Ratios:
For a deeper understanding of Nutex Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.52. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.27. In the meantime, Its Debt-to-Equity ratio is 1.73 whereas as Long-Term Debt/Eq ratio is at 1.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on November 12, 2024, Reiterated its Buy rating but revised its target price to $50 from $45 previously.
On September 18, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $45.
On February 22, 2023, Northland Capital started tracking the stock assigning a Outperform rating and target price of $3.Northland Capital initiated its Outperform rating on February 22, 2023, with a $3 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 08 ’25 when Bates Jon Christian bought 1,000 shares for $81.81 per share. The transaction valued at 81,810 led to the insider holds 4,888 shares of the business.
Bates Jon Christian bought 1,350 shares of NUTX for $28,970 on Aug 22 ’24. The Chief Financial Officer now owns 2,277 shares after completing the transaction at $21.46 per share. On Aug 19 ’24, another insider, DeTillio Joshua, who serves as the Chief Operating Officer of the company, bought 1,300 shares for $17.85 each. As a result, the insider paid 23,205 and bolstered with 4,233 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUTX now has a Market Capitalization of 661059264 and an Enterprise Value of 996719808. As of this moment, Nutex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.00, and their Forward P/E ratio for the next fiscal year is 10.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.06 while its Price-to-Book (P/B) ratio in mrq is 3.34. Its current Enterprise Value per Revenue stands at 1.597 whereas that against EBITDA is 4.386.
Stock Price History:
The Beta on a monthly basis for NUTX is 0.06, which has changed by 19.804195 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, NUTX has reached a high of $184.27, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is -12.65%, while the 200-Day Moving Average is calculated to be 92.01%.
Shares Statistics:
For the past three months, NUTX has traded an average of 140.95K shares per day and 173570 over the past ten days. A total of 5.53M shares are outstanding, with a floating share count of 3.54M. Insiders hold about 36.21% of the company’s shares, while institutions hold 18.30% stake in the company. Shares short for NUTX as of 1748563200 were 213912 with a Short Ratio of 1.52, compared to 1745971200 on 118725. Therefore, it implies a Short% of Shares Outstanding of 213912 and a Short% of Float of 5.9699997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
